The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer
Open accessAbstract
Purpose: To examine the association between beta-blocker (BB) intake, pathologic complete response (pCR) rates, and survival outcomes in patients with breast cancer treated with neoadjuvant chemotherapy. Patients and Methods: We retrospectively reviewed 1,413 patients with breast cancer who received neoadjuvant chemotherapy between 1995 and 2007. Patients taking BBs at the start of neoadjuvant therapy were compared with patients with no BB intake. Rates of pCR between the groups were compared using a χ 2 test. Cox proportional hazards models were fitted to determine the association between BB intake, relapse-free survival (RFS), and overall survival (OS). Results: Patients who used BBs (n = 102) were compared with patients (n = 1,311) who did not. Patients receiving BBs tended to be older and obese (P < .001). The proportion of pCR was not significantly different between the groups (P = .48). After adjustment for age, race, stage, grade, receptor status, lymphovascular invasion, body mass index, diabetes, hypertension, and angiotensin-converting enzyme inhibitor use, BB intake was associated with a significantly better RFS (hazard ratio [HR], 0.52; 95% CI, 0.31 to 0.88) but not OS (P = .09). Among patients with triple-negative breast cancer (TNBC; n = 377), BB intake was associated with improved RFS (HR, 0.30; 95% CI, 0.10 to 0.87;P = .027) but not OS (HR, 0.35; 95% CI, 0.12 to 1.00;P = .05). Conclusion: In this study, BB intake was associated with improved RFS in all patients with breast cancer and in patients with TNBC. Additional studies evaluating the potential benefits of beta-adrenergic blockade on breast cancer recurrence with a focus on TNBC are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Multiple Imputation for Nonresponse in Surveys
Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701
Psychological Stress and Disease
Cohen, S., Janicki-Deverts, D., & Miller, G. E. (2007) · JAMA · doi:10.1001/jama.298.14.1685 · Cited by 3,168
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Rastogi, P., Anderson, S. J., Bear, H. D., Geyer, C. E., Kahlenberg, M. S., Robidoux, A., Margolese, R. G., Hoehn, J. L., Vogel, V. G., Dakhil, S. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0235 · Cited by 1,789 · cited 1×
“Neoadjuvant chemotherapy permits assessment of tumor sensitivity to a specific therapy thereby providing insight into tumor biology.(31) In this single-institution study, we set out to determine whether beta-blocker use associates with breast cancer primary tumor response and survival outcome.”
BackgroundChronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationHaffty, B. G., Yang, Q., Reiss, M., Kearney, T., Higgins, S. A., Weidhaas, J., Harris, L., Hait, W., & Toppmeyer, D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5664 · Cited by 1,084
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
Self-citationThe sympathetic nervous system induces a metastatic switch in primary breast cancer
Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0522 · Cited by 930
Self-citationEpidemiology of basal-like breast cancer
Millikan, R. C., Newman, B., Tse, C.-K., Moorman, P. G., Conway, K., Smith, L. V., Labbok, M. H., Geradts, J., Bensen, J. T., Jackson, S., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9632-6 · Cited by 886
Jiralerspong, S., Palla, S. L., Giordano, S. H., Meric-Bernstam, F., Liedtke, C., Barnett, C. M., Hsu, L., Hung, M.-C., Hortobagyi, G. N., & Gonzalez-Angulo, A. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.19.6410 · Cited by 880
Self-citationTriple-negative breast cancer: disease entity or title of convenience?
Carey, L., Winer, E., Viale, G., Cameron, D., & Gianni, L. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.154 · Cited by 783
Lin, N. U., Claus, E., Sohl, J., Razzak, A. R., Arnaout, A., & Winer, E. P. (2008) · Cancer · doi:10.1002/cncr.23930 · Cited by 727
Guarneri, V., Broglio, K., Kau, S.-W., Cristofanilli, M., Buzdar, A. U., Valero, V., Buchholz, T., Meric, F., Middleton, L., Hortobagyi, G. N., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.6914 · Cited by 601
Self-citationPsychologic intervention improves survival for breast cancer patients: A randomized clinical trial
Andersen, B. L., Yang, H., Farrar, W. B., Golden‐Kreutz, D. M., Emery, C. F., Thornton, L. M., Young, D. C., & Carson, W. E. (2008) · Cancer · doi:10.1002/cncr.23969 · Cited by 493
Powe, D. G., Voss, M. J., Zänker, K. S., Habashy, H. O., Green, A. R., Ellis, I. O., & Entschladen, F. (2010) · Oncotarget · doi:10.18632/oncotarget.197 · Cited by 453
Yang, E. V., Sood, A. K., Chen, M., Li, Y., Eubank, T. D., Marsh, C. B., Jewell, S., Flavahan, N. A., Morrison, C., Yeh, P.-E., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2496 · Cited by 407
Self-citationMolecular mechanisms of β2-adrenergic receptor function, response, and regulation
Johnson, M. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.11.012 · Cited by 384
Stress, Visceral Obesity, and Metabolic Complications
KYROU, I., CHROUSOS, G. P., & TSIGOS, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.008 · Cited by 380
Lambert, G. W., Straznicky, N. E., Lambert, E. A., Dixon, J. B., & Schlaich, M. P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.002 · Cited by 347
Mak, J. C., Nishikawa, M., Shirasaki, H., Miyayasu, K., & Barnes, P. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118084 · Cited by 251
Host Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions
Lutgendorf, S. K., Sood, A. K., & Antoni, M. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9357 · Cited by 237
Self-citationSurgical Stress Promotes Tumor Growth in Ovarian Carcinoma
Lee, J.-W., Shahzad, M. M. K., Lin, Y. G., Armaiz-Pena, G., Mangala, L. S., Han, H.-D., Kim, H.-S., Nam, E. J., Jennings, N. B., Halder, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2966 · Cited by 210
Self-citationLitton, J. K., Gonzalez-Angulo, A. M., Warneke, C. L., Buzdar, A. U., Kau, S.-W., Bondy, M., Mahabir, S., Hortobagyi, G. N., & Brewster, A. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4527 · Cited by 206
Self-citationChrousos, G. P., & Kino, T. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04988.x · Cited by 186
Nilsson, M. B., Armaiz-Peña, G. N., Takahashi, R., Lin, Y. G., Trevino, J. G., Li, Y., Jennings, N., Arevalo, J. M. G., Lutgendorf, S. K., Gallick, G. E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611539200 · Cited by 181
Self-citationWu, W., Pew, T., Zou, M., Pang, D., & Conzen, S. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411200200 · Cited by 177
Self-citationModulation of glucocorticoid receptor function by protein kinase A
Rangarajan, P. N. (1992) · Molecular Endocrinology · doi:10.1210/me.6.9.1451 · Cited by 168
Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population
Vona-Davis, L. C., Rose, D. P., Hazard-Jenkins, H. W., Howard-McNatt, M. M., Adkins, F. C., Partin, J. F., & Hobbs, G. R. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0544 · Cited by 154
The association of metabolic syndrome with triple-negative breast cancer
Maiti, B., Kundranda, M. N., Spiro, T. P., & Daw, H. A. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0591-y · Cited by 147
Beta-Blocker Selectivity at Cloned Human Beta1- and Beta2-Adrenergic Receptors
Smith, C., & Teitler, M. (1999) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007784109255 · Cited by 144
Williams, J. B., Pang, D., Delgado, B., Kocherginsky, M., Tretiakova, M., Krausz, T., Pan, D., He, J., McClintock, M. K., & Conzen, S. D. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0238 · Cited by 137
Self-citationThe mechanism of cAMP-induced Glucocorticoid Receptor Expression
Dong, Y., Aronsson, M., Gustafsson, J. A., & Okret, S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80050-3 · Cited by 135
Davies, A. O., & Lefkowitz, R. J. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-4-703 · Cited by 100
Melhem‐Bertrandt, A., Yamada, S. D., Fleming, G. F., Delgado, B., Brickley, D. R., Wu, W., Kocherginsky, M., & Conzen, S. D. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2131 · Cited by 98
Self-citationA cohort study of antihypertensive treatments and risk of renal cell cancer
Fryzek, J. P., Poulsen, A. H., Johnsen, S. P., McLaughlin, J. K., Sørensen, H. T., & Friis, S. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602490 · Cited by 71
Huang, X., Hamajima, N., Saito, T., Matsuo, K., Mizutani, M., Iwata, H., Iwase, T., Miura, S., Mizuno, T., Tokudome, S., et al. (2001) · Breast Cancer Research · doi:10.1186/bcr304 · Cited by 64
Medication use and the risk of breast cancer
Davis, S., & Mirick, D. K. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9135-0 · Cited by 43
Draoui, A., Vandewalle, B., Hornez, L., Révillion-Carette, F., & Lefèbvre, J. L. (1991) · PubMed · Cited by 42
SGK1, a potential regulator of c-fms related breast cancer aggressiveness
Tangir, J., Bonafé, N., Gilmore-Hebert, M., Henegariu, O., & Chambers, S. K. (2004) · Clinical & Experimental Metastasis · doi:10.1007/s10585-004-4226-8 · Cited by 42
Silbergeld, E. K., & Calne, D. B. (1981) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(81)90079-6 · Cited by 39
Call, R., Grimsley, M., Cadwallader, L., Cialone, L., Hill, M., Hreish, V., King, S., & Riche, D. M. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2153 · Cited by 37
Bisphosphonates in breast cancer: teaching an old dog new tricks
Winter, M. C., & Coleman, R. E. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328331c794 · Cited by 32
Basile, J. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.04.013 · Cited by 12
The Relationship Between Psychosocial Stressors and Breast Cancer Biology
Melhem‐Bertrandt, A., & Conzen, S. D. (2010) · Current Breast Cancer Reports · doi:10.1007/s12609-010-0021-5 · Cited by 11
Self-citation
Cited by
Autonomic nerve development contributes to prostate cancer progression
Magnon, C., Hall, S. J., Lin, J., Xue, X., Gerber, L., Freedland, S. J., & Frenette, P. S. (2013) · Science · doi:10.1126/science.1236361 · Cited by 1,287
Mehta, L. S., Watson, K. E., Barac, A., Beckie, T. M., Bittner, V., Cruz-Flores, S., Dent, S., Kondapalli, L., Ky, B., Okwuosa, T., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000556 · Cited by 848
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Cole, S. W., & Sood, A. K. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0641 · Cited by 681
Self-citationSympathetic nervous system regulation of the tumour microenvironment
Cole, S. W., Nagaraja, A. S., Lutgendorf, S. K., Green, P. A., & Sood, A. K. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3978 · Cited by 576
Self-citationPetrelli, F., Cortellini, A., Indini, A., Tomasello, G., Ghidini, M., Nigro, O., Salati, M., Dottorini, L., Iaculli, A., Varricchio, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.3520 · Cited by 530
Metadata
- Authors
- Melhem-Bertrandt, A., Chavez-MacGregor, M., Lei, X., Brown, E. N., Lee, R. T., Meric-Bernstam, F., Sood, A. K., Conzen, S. D., Hortobagyi, G. N., & Gonzalez-Angulo, A.-M.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-07-01
- Volume
- 29
- Issue
- 19
- Pages
- 2645-2652
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2118147608
- Cited by
- 464
- References
- 45
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.